Rhizopogon luteolus and Ganoderma adspersum Extracts Inhibit Invasion through the Crosstalk between Anti-oxidant

Aydın Demiray1, Ege Rıza Karagür1, Gülsen Tel-Cayan2

  • 1Department of Medical Genetic, School of Medicine, Pamukkale University, Denizli, Turkey.

Abstract

Insights

Mushroom extracts from Rhizopogon luteolus and Ganoderma adspersum show promise in fighting non-small cell lung cancer. These natural compounds inhibit cancer cell proliferation and invasion while promoting apoptosis, offering a potential new avenue for lung cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Mycology

Background:

  • Lung cancer is a leading cause of cancer mortality worldwide.
  • Protein kinase B (AKT) signaling pathways are implicated in non-small cell lung cancer (NSCLC) progression.
  • Mushrooms possess known antioxidant and anticancer properties, prompting investigation into their therapeutic potential.

Purpose of the Study:

  • To investigate the antioxidant, anti-invasion, and apoptosis-inducing effects of mushroom extracts in NSCLC.
  • To explore the underlying molecular mechanisms, including the AKT-Rb pathway.

Main Methods:

  • Utilized NSCLC cell lines (H1299, PC-3, PC-14).
  • Prepared and applied extracts of *Rhizopogon luteolus* and *Ganoderma adspersum* at calculated IC50 doses.
  • Assessed antiproliferative, anti-invasive, antioxidant, and apoptosis-inducing effects.
  • Employed Western blotting to analyze relevant signaling pathways.

Main Results:

  • Both *R. luteolus* and *G. adspersum* extracts demonstrated significant anti-proliferative and anti-invasive effects on NSCLC cells.
  • The mushroom extracts successfully induced apoptosis in cancer cells.
  • Enhanced antioxidant activity was observed, linked to the AKT-Rb pathway.

Conclusions:

  • *Rhizopogon luteolus* and *Ganoderma adspersum* extracts exhibit potent anticancer properties against NSCLC.
  • These extracts suppress lung cancer cell growth and invasion by modulating the p-Akt and Rb pathways.
  • Mushroom-derived compounds represent a promising therapeutic strategy for lung cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K